MYC and breast cancer: To determine whether the effect of salicylate on AMPK activation and c-Myc degradation was a general effect, we investigated the association between AMPK activation and c-Myc levels in U2OS osteosarcoma cells and MCF-7 breast cancer cells (Figure 3A and Figure 3B, respectively).